These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21931024)

  • 1. Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.
    Talcott JA; Yeap BY; Clark JA; Siegel RD; Loggers ET; Lu C; Godley PA
    J Clin Oncol; 2011 Oct; 29(30):3977-83. PubMed ID: 21931024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.
    Teuffel O; Amir E; Alibhai S; Beyene J; Sung L
    Br J Cancer; 2011 Apr; 104(9):1377-83. PubMed ID: 21468048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.
    Alali M; Prather C; Danziger-Isakov LA; Kussin ML; Khalifeh M; Al Othman N; Bartlett AH
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e702-e709. PubMed ID: 37494607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings.
    Okera M; Chan S; Dernede U; Larkin J; Popat S; Gilbert D; Jones L; Osuji N; Sykes H; Oakley C; Pickering L; Lofts F; Chowdhury S
    Br J Cancer; 2011 Feb; 104(3):407-12. PubMed ID: 21179036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to antibiotics and outcomes in cancer patients with febrile neutropenia.
    Perron T; Emara M; Ahmed S
    BMC Health Serv Res; 2014 Apr; 14():162. PubMed ID: 24716604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial.
    Ram R; Amit O; Adler A; Bar-On Y; Beyar-Katz O; Avivi I; Shasha D; Ben-Ami R
    Transplant Cell Ther; 2023 Nov; 29(11):708.e1-708.e8. PubMed ID: 37591446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a safe neutrophil count for cessation of intravenous antibiotics and early hospital discharge in stable, afebrile patients recovering after acute myeloid leukemia therapy or an autograft.
    Hu CC; Subramanian R; Grigg A
    Leuk Lymphoma; 2023; 64(7):1322-1329. PubMed ID: 37081819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Children Discharged Prior to Absolute Neutrophil Count Recovery After Admission for Febrile Neutropenia.
    Peters S; Adler M; Rossoff J
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e948-e952. PubMed ID: 37700440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs.
    Andrès E; Mourot-Cottet R; Maloisel F; Keller O; Vogel T; Séverac F; Tebacher M; Gottenberg JE; Weber JC; Kaltenbach G; Goichot B; Sibilia J; Korganow AS; Herbrecht R
    J Clin Med; 2017 Sep; 6(10):. PubMed ID: 28954408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy induced febrile neutropenia: management and prevention.
    Marshall E; Innes H
    Clin Med (Lond); 2008 Aug; 8(4):448-51. PubMed ID: 18724618
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy-induced febrile neutropenia.
    Temblett P
    Clin Med (Lond); 2008 Dec; 8(6):634; author reply 634. PubMed ID: 19149289
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Better at home": Mixed methods report of intricacies in pediatric febrile neutropenia management.
    Cancer Med; 2024 Jun; 13(12):e7373. PubMed ID: 38923352
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
    Weycker D; Barron R; Kartashov A; Legg J; Lyman GH
    J Oncol Pharm Pract; 2014 Jun; 20(3):190-8. PubMed ID: 23824496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study.
    Jolis L; Carabantes F; Pernas S; Cantos B; López A; Torres P; Funes C; Caballero D; Benedit P; Salar A;
    Eur J Cancer Care (Engl); 2013 Jul; 22(4):513-21. PubMed ID: 23730920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
    J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial.
    Hendricks AM; Loggers ET; Talcott JA
    J Clin Oncol; 2011 Oct; 29(30):3984-9. PubMed ID: 21931037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient-level care at home delivered by virtual wards and hospital at home: a systematic review and meta-analysis of complex interventions and their components.
    Shi C; Dumville J; Rubinstein F; Norman G; Ullah A; Bashir S; Bower P; Vardy ERLC
    BMC Med; 2024 Apr; 22(1):145. PubMed ID: 38561754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
    Coyle V; Forde C; Adams R; Agus A; Barnes R; Chau I; Clarke M; Doran A; Grayson M; McAuley D; McDowell C; Phair G; Plummer R; Storey D; Thomas A; Wilson R; McMullan R
    Health Technol Assess; 2024 Mar; 28(14):1-101. PubMed ID: 38512064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission avoidance hospital at home.
    Edgar K; Iliffe S; Doll HA; Clarke MJ; Gonçalves-Bradley DC; Wong E; Shepperd S
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD007491. PubMed ID: 38438116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.